Treatment of pediatric acute lymphoblastic leukemia. - Wikidata - awgldk - TriplyDB

Treatment of pediatric acute lymphoblastic leukemia.

Treatment of pediatric acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q35196702

about

Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial Identification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemia Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.Effects of the application of therapeutic massage in children with cancer: a systematic review.The contributions of the European Medicines Agency and its pediatric committee to the fight against childhood leukemia Butein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathway L-Asparaginase Isolated from Phaseolus vulgaris Seeds Exhibited Potent Anti-Acute Lymphoblastic Leukemia Effects In-Vitro and Low Immunogenic Properties In-Vivo.Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations.Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents.Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia.The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood.Treatment of Young Adults with Acute Lymphoblastic Leukemia.Continuing challenges and current issues in acute lymphoblastic leukemia.Inferior outcomes for black children with high risk acute lymphoblastic leukemia and the impact of socioeconomic variables.Role of peripheral blood minimum residual disease at day 8 of induction therapy in high-risk pediatric patients with acute lymphocytic leukemia Invasive fungal infection (IFI) in pediatric leukemia: better outcome with ACT.Voriconazole plus caspofungin for treatment of invasive fungal infection in children with acute leukemia.CARs on a highway with roadblocks.Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy.Changes in cognition and dendritic complexity following intrathecal methotrexate and cytarabine treatment in a juvenile murine model.Treatment of vincristine-induced ileus with metoclopramide: A case report.A retrospective comparison of Escherichia coli and polyethylene glycol-conjugated asparaginase for the treatment of adolescents and adults with newly diagnosed acute lymphoblastic leukemia.Effects of 1,3,5-triphenyl-4,5-dihydro-1H-pyrazole derivatives on cell-cycle and apoptosis in human acute leukemia cell lines.CD47-ligation induced cell death in T-acute lymphoblastic leukemia.Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients Bone relapse in T-lineage acute lymphoblastic leukemia in a child The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia Histidine catabolism is a major determinant of methotrexate sensitivity

P2860

Q28066265-C87656FF-73AB-469E-AE4B-77DBB8141F26 Q28553697-58310B27-27B1-4357-9A8F-544672D5B91F Q33632120-6695B83E-C45A-4B0C-8081-DDF86778DAAA Q33655100-9F5DCD5B-CD5B-4799-99B7-6501ADF9B4DD Q33714739-6480D317-AFDB-469F-8A3C-A32C6F08EE12 Q33761600-0718F334-1E9F-4454-B16D-6AC76FAEE7AC Q33857782-A94F07CC-9A21-45F8-AFE3-59B54BDD59B2 Q36267151-C6E32E77-DDC6-442F-8C4C-4F3C23934219 Q37109845-D96CAFA8-5D4A-43F2-ABBE-75B7719949DB Q37379199-347AF965-FE01-4B42-B5E7-813D6A756DFF Q38688039-ED990171-BB05-45D3-9B27-F0FD42EBB111 Q38701181-23E62CBD-FB01-4890-B92D-004A746538BF Q38797514-1DEC1828-DB88-4598-A095-C9B312440133 Q38821455-756FC15A-7080-4454-8BB2-10D93CEFE622 Q38840423-F6FDFE41-9AFB-4C4C-8F7D-16AD953DAD83 Q38840936-F2EBF8AD-9214-492C-8BD4-F28D64525C99 Q39002810-D85C24BC-7DCC-49C6-887A-CF1EAA178E93 Q39206217-40DB02C3-C666-432E-9ED5-9E986D1FFBF3 Q39366299-683522A0-5E49-4379-9B3D-C89EB7391AEE Q39369458-FB7AF67F-A972-484E-9052-08618052A9E6 Q41981064-3B434470-38E4-47C8-8A1C-94D1FB7FBE35 Q42377766-7859CC40-1E96-4F04-85AC-E5EDD7576D71 Q42377772-BE59BEA7-2DD9-438F-8A17-BE6053DF9EF3 Q45875485-86AD5D66-DAA9-46FE-85B4-D3B2A6ACA238 Q46844249-29D60B2B-30BE-4CB7-AF84-61BF4114714F Q47327834-C58C9980-2B70-4D30-AA0A-FC86F269FA81 Q48147607-A12B0BE1-1F31-4C2D-B0D1-5034E4BCA8A0 Q49412789-B1220091-B3A5-4835-AB17-C4CAF401B080 Q52793168-F68F55DD-F481-4119-84B2-BE3314541442 Q55025781-125FE170-8032-40AA-9A56-F5E34DCAFC78 Q57138588-0AD6158F-1FB3-4D7F-A653-4C12FA949428 Q57816122-744C24E7-8472-4367-BE9E-D9FC6C2312BF Q58701685-F5502B88-7271-4832-8F8B-18974B546CAF Q58767159-722DCB7F-5FE9-41BC-8504-7B499D592F51 Q58776389-D01335B6-1F10-4AD3-B8F0-EED841A65E3C Q59071518-F83D366A-11EC-465C-A97E-6E5502C6FA07

P2860

Treatment of pediatric acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q35196702

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Treatment of pediatric acute lymphoblastic leukemia.

@ast

Treatment of pediatric acute lymphoblastic leukemia.

@en

type

label

Treatment of pediatric acute lymphoblastic leukemia.

@ast

Treatment of pediatric acute lymphoblastic leukemia.

@en

prefLabel

Treatment of pediatric acute lymphoblastic leukemia.

@ast

Treatment of pediatric acute lymphoblastic leukemia.

@en

P1433

Q35196702-65E7EDB2-6100-41A4-A15B-547FA0AE8573

P1476

Q35196702-FF8F2157-1485-4611-AD80-936715033986

P2093

Q35196702-C836657C-E2DD-49A0-89DC-2991A64775EA

Q35196702-F2005F08-CC9F-45E5-988D-FCF3E89A3743

P2860

Q35196702-0198F0AD-ED27-4334-84AD-B68371FC800B

Q35196702-091779A3-8093-4F70-BBBF-9FBE21661919

Q35196702-0A01D59E-E7B6-4FA5-BC75-203628124DD1

Q35196702-0C981CEC-0194-42D0-B10B-10F9C06BF501

Q35196702-0FC8D44C-8F14-431E-AD5B-EDDEB02AAC80

Q35196702-166CF89E-082A-4110-A32F-DDC88458162A

Q35196702-184ADDF0-D76B-4CA4-A2A2-65EB2B7FF8F0

Q35196702-1861B15A-CD32-4331-A5DF-7C31D02342AA

Q35196702-1AE13362-DF84-4127-BAF0-BA46D5EC3EA9

Q35196702-2196889D-8224-4018-B865-3A79BFD03236

P304

Q35196702-ED5102ED-059A-4668-90F9-684E0332B531

P31

Q35196702-F197559C-6C01-4039-AF1F-61E01BA221E5

P356

Q35196702-C937C68A-8494-4906-BC02-FA3D79396592

P433

Q35196702-58971220-B674-46C7-912D-14B2218D3D79

P478

Q35196702-823AA19C-BA03-4339-A9AF-DA0D547205BE

P577

Q35196702-73D1B036-76FB-4AA9-B335-BAF5D8EA5CCC

P698

Q35196702-D3A54A70-EBCC-4DB0-A482-4D81B6F76D7E

P921

Q35196702-A9923D37-DECA-4948-B77A-ABED55D5EB99

P932

Q35196702-5858A25B-3CC4-4823-942F-549DAEF6B2D4

P356

J.PCL.2014.09.006

P1433

Pediatric Clinics of North America

P1476

Treatment of pediatric acute lymphoblastic leukemia.

@en

P2093

Patrick A Brown

http://www.w3.org/2001/XMLSchema#string

Stacy L Cooper

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

Treating childhood acute lymphoblastic leukemia without cranial irradiation

Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.

Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.

Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia - an individual patient data meta-analysis involving 5,659 children.

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.

Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox

Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.

Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group

P304

61-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PCL.2014.09.006

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25435112

http://www.w3.org/2001/XMLSchema#string

P921

P932

4366417

http://www.w3.org/2001/XMLSchema#string